AI Accelerates and Expands Drug Development

January 6, 2025 UCBN News, Syndication Comments Off on AI Accelerates and Expands Drug Development

The most familiar artificial intelligence (AI) applications include text generation, facial recognition, and autonomous driving. But there are other AI applications that deserve their share of attention.

The post AI Accelerates and Expands Drug Development appeared first on GEN – Genetic Engineering and Biotechnology News.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Salt Lake City Oculofacial Plastic Surgeon Dr. Kian Eftekhari was Recently the Education Program Chair at the Utah Ophthalmology Society Annual Conference

May 7, 2024 UCBN News, Syndication Comments Off on Salt Lake City Oculofacial Plastic Surgeon Dr. Kian Eftekhari was Recently the Education Program Chair at the Utah Ophthalmology Society Annual Conference

Dr. Kian Eftekhari’s recent role as Education Program Chair at the Utah Ophthalmology Society Annual Conference highlights his leadership in advancing oculofacial plastic surgery, while his practice the Eyelid Center of Utah underscores his commitment […]

News

MTN OPS Partners with Nu Skin and Utah Jazz to Set New GUINNESS WORLD RECORDS™ Title for the Most People Packing Meal Kits in 24 Hours

August 1, 2024 UCBN News, Syndication Comments Off on MTN OPS Partners with Nu Skin and Utah Jazz to Set New GUINNESS WORLD RECORDS™ Title for the Most People Packing Meal Kits in 24 Hours

To commemorate the company’s 10th anniversary, MTN OPS helped to pack more than 550,000 meals for children throughout the United States FRUIT HEIGHTS, Utah, Aug. 1, 2024 /PRNewswire/ — MTN OPS is proud to announce […]

No Picture
News

BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting

April 24, 2023 UCBN News Comments Off on BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting

PARK CITY, Utah, April 24, 2023 /PRNewswire/ — BlueWind Medical, Ltd., the developer of transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced that efficacy results of the OASIS pivotal clinical study will […]